BETHKIS vs KIMYRSA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. BETHKIS and KIMYRSA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BETHKIS	KIMYRSA
Rating	70/100	New
Pharmacy pays	$1.08 /mL	—
Type	RX	RX
Active ingredient	TOBRAMYCIN	ORITAVANCIN DIPHOSPHATE
Manufacturer	Chiesi	Melinta Therap
Dosage forms	Solution	Injectable
Drug class	Aminoglycoside Antibacterial	Lipoglycopeptide Antibacterial
Boxed warning	None	None
Treats	Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections	Infectious Skin Diseases, Staphylococcal Infections, Streptococcal Infections

bethkis kimyrsa

Rating

70/100

New

Pharmacy pays

$1.08 /mL

—

Type

Active ingredient

TOBRAMYCIN

ORITAVANCIN DIPHOSPHATE

Manufacturer

Chiesi

Melinta Therap

Dosage forms

Solution

Injectable

Drug class

Aminoglycoside Antibacterial

Lipoglycopeptide Antibacterial

Boxed warning

None

Treats

Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections

Infectious Skin Diseases, Staphylococcal Infections, Streptococcal Infections

Frequently asked questions

What is the difference between Bethkis and Kimyrsa?

Bethkis contains Tobramycin, while Kimyrsa contains Oritavancin Diphosphate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.